BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31520867)

  • 1. Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey.
    Levy A; Hendriks LEL; Le Péchoux C; Falk S; Besse B; Novello S; Dingemans AC; Hasan B; Reck M; Berghmans T; Faivre-Finn C;
    Lung Cancer; 2019 Oct; 136():145-147. PubMed ID: 31520867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for the CONVERT trial-Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status.
    Faivre-Finn C; Falk S; Ashcroft L; Bewley M; Lorigan P; Wilson E; Groom N; Snee M; Fournel P; Cardenal F; Bezjak A; Blackhall F
    BMJ Open; 2016 Jan; 6(1):e009849. PubMed ID: 26792218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial.
    Tay RY; Fernández-Gutiérrez F; Foy V; Burns K; Pierce J; Morris K; Priest L; Tugwood J; Ashcroft L; Lindsay CR; Faivre-Finn C; Dive C; Blackhall F
    Ann Oncol; 2019 Jul; 30(7):1114-1120. PubMed ID: 31020334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer Patients: Secondary Findings From the Prospective Randomized Phase 3 CONVERT Trial.
    Levy A; Le Péchoux C; Mistry H; Martel-Lafay I; Bezjak A; Lerouge D; Padovani L; Taylor P; Faivre-Finn C
    J Thorac Oncol; 2019 Feb; 14(2):294-297. PubMed ID: 30292850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation therapy in small cell lung cancer: a national Italian survey.
    Ciammella P; Timon G; Bruni A; Franceschini D; Borghetti P; Giaj-Levra N; Greco C; Scotti V; Trovo M;
    Radiol Med; 2018 Jul; 123(7):554-560. PubMed ID: 29536412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation Dose and Fractionation for Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Practice Patterns.
    Farrell MJ; Yahya JB; Degnin C; Chen Y; Holland JM; Henderson MA; Jaboin JJ; Harkenrider MM; Thomas CR; Mitin T
    Clin Lung Cancer; 2019 Jan; 20(1):13-19. PubMed ID: 30219240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of treatment and care practices in small-cell lung cancer among German radiation oncologists.
    Gnüchtel J; Vordermark D; Medenwald D
    Strahlenther Onkol; 2023 Jul; 199(7):631-644. PubMed ID: 36418442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of pulmonary toxicity in limited stage small cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904.
    Salama JK; Pang H; Bogart JA; Blackstock AW; Urbanic JJ; Hogson L; Crawford J; Vokes EE
    Lung Cancer; 2013 Dec; 82(3):436-40. PubMed ID: 24396884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of recommended procedures for lung cancer staging and management in the United States over 10 years: a quality research in radiation oncology survey.
    Komaki R; Khalid N; Langer CJ; Kong FM; Owen JB; Crozier CL; Wilson JF; Wei X; Movsas B
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1082-9. PubMed ID: 23273996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the optimal radiotherapy schedule for limited stage small cell lung cancer?
    Slotman B
    Lung Cancer; 2017 Mar; 105():52-53. PubMed ID: 28095982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of thoracic radiotherapy timing and duration on progression-free survival in limited-stage small cell lung cancer.
    Zhao S; Zhou T; Ma S; Zhao Y; Zhan J; Fang W; Yang Y; Hou X; Zhang Z; Chen G; Zhang Y; Huang Y; Zhang L
    Cancer Med; 2018 Sep; 7(9):4208-4216. PubMed ID: 30019533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients.
    Stinchcombe TE; Fan W; Schild SE; Vokes EE; Bogart J; Le QT; Thomas CR; Edelman MJ; Horn L; Komaki R; Cohen HJ; Kishor Ganti A; Pang H; Wang X
    Cancer; 2019 Feb; 125(3):382-390. PubMed ID: 30343497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns.
    Farrell MJ; Yahya JB; Degnin C; Chen Y; Holland JM; Henderson MA; Jaboin JJ; Harkenrider MM; Thomas CR; Mitin T
    Clin Lung Cancer; 2018 Jul; 19(4):371-376. PubMed ID: 29559208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of Thoracic Radiation Therapy With Chemotherapy in Limited-stage Small-cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns.
    Farrell MJ; Yahya JB; Degnin C; Chen Y; Holland JM; Henderson MA; Jaboin JJ; Harkenrider MM; Thomas CR; Mitin T
    Clin Lung Cancer; 2018 Nov; 19(6):e815-e821. PubMed ID: 29857969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer.
    Chu X; Li S; Xia B; Chu L; Yang X; Ni J; Zou L; Li Y; Xie C; Lin J; Zhu Z
    Radiat Oncol; 2019 Sep; 14(1):171. PubMed ID: 31533763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of PET staging in limited-stage small-cell lung cancer.
    Xanthopoulos EP; Corradetti MN; Mitra N; Fernandes AT; Kim M; Grover S; Christodouleas JP; Evans TL; Stevenson JP; Langer CJ; Lee TT; Pryma DA; Lin LL; Simone CB; Apisarnthanarax S; Rengan R
    J Thorac Oncol; 2013 Jul; 8(7):899-905. PubMed ID: 23608814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer.
    Colaco RJ; Huh S; Nichols RC; Morris CG; D'Agostino H; Flampouri S; Li Z; Pham DC; Bajwa AA; Hoppe BS
    Acta Oncol; 2013 Apr; 52(3):506-13. PubMed ID: 23438357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Advanced Imaging in Assessing Response to Definitive Chemoradiation Before Prophylactic Cranial Irradiation in Limited-Stage Small-Cell Lung Cancer.
    Kesarwala AH; Lu DJ; Xanthopoulos E; Apisarnthanarax S; Cengel KA; Evans TL; Aggarwal C; Cohen RB; Langer CJ; Rengan R; Simone CB
    Clin Lung Cancer; 2018 Mar; 19(2):e205-e209. PubMed ID: 29153967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When is surgery indicated for small-cell lung cancer?
    Veronesi G; Bottoni E; Finocchiaro G; Alloisio M
    Lung Cancer; 2015 Dec; 90(3):582-9. PubMed ID: 26520187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in study on the therapy for limited-stage small cell lung cancer].
    Zhang H; Liu Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 38(8):857-62. PubMed ID: 23982001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.